HBIO
Price
$0.47
Change
-$0.01 (-2.08%)
Updated
Sep 8, 12:49 PM (EDT)
Capitalization
21.29M
59 days until earnings call
SERA
Price
$3.34
Change
-$0.07 (-2.05%)
Updated
Sep 5 closing price
Capitalization
127.13M
58 days until earnings call
Interact to see
Advertisement

HBIO vs SERA

Header iconHBIO vs SERA Comparison
Open Charts HBIO vs SERABanner chart's image
Harvard Bioscience
Price$0.47
Change-$0.01 (-2.08%)
Volume$150
Capitalization21.29M
Sera Prognostics
Price$3.34
Change-$0.07 (-2.05%)
Volume$76.38K
Capitalization127.13M
HBIO vs SERA Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. SERA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and SERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (HBIO: $0.48 vs. SERA: $3.34)
Brand notoriety: HBIO and SERA are both not notable
HBIO represents the Pharmaceuticals: Other, while SERA is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 47% vs. SERA: 64%
Market capitalization -- HBIO: $21.29M vs. SERA: $127.13M
HBIO [@Pharmaceuticals: Other] is valued at $21.29M. SERA’s [@Medical/Nursing Services] market capitalization is $127.13M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileSERA’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • SERA’s FA Score: 0 green, 5 red.
According to our system of comparison, HBIO is a better buy in the long-term than SERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 4 TA indicator(s) are bullish while SERA’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 4 bullish, 4 bearish.
  • SERA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both HBIO and SERA are a good buy in the short-term.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а -3.39% price change this week, while SERA (@Medical/Nursing Services) price change was +3.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 06, 2025.

SERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SERA($127M) has a higher market cap than HBIO($21.3M). SERA YTD gains are higher at: -58.968 vs. HBIO (-77.336). SERA has higher annual earnings (EBITDA): -31.85M vs. HBIO (-46.8M). SERA has more cash in the bank: 40.2M vs. HBIO (7.44M). SERA has less debt than HBIO: SERA (351K) vs HBIO (43.3M). HBIO has higher revenues than SERA: HBIO (88.8M) vs SERA (108K).
HBIOSERAHBIO / SERA
Capitalization21.3M127M17%
EBITDA-46.8M-31.85M147%
Gain YTD-77.336-58.968131%
P/E RatioN/AN/A-
Revenue88.8M108K82,222%
Total Cash7.44M40.2M19%
Total Debt43.3M351K12,336%
FUNDAMENTALS RATINGS
HBIO: Fundamental Ratings
HBIO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HBIOSERA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 29 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YSG9.390.60
+6.83%
Yatsen Holding Limited
JBDI1.020.05
+5.14%
JBDI Holdings Ltd
IMO87.28-0.19
-0.22%
Imperial Oil Limited
GBTG8.11-0.03
-0.37%
Global Business Travel Group
PERF1.92-0.02
-1.03%
Perfect Corp

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
+2.20%
IRMD - HBIO
51%
Loosely correlated
-0.21%
SGHT - HBIO
39%
Loosely correlated
-1.07%
A - HBIO
38%
Loosely correlated
+0.21%
TMO - HBIO
35%
Loosely correlated
+0.64%
MTD - HBIO
35%
Loosely correlated
+1.39%
More

SERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SERA has been loosely correlated with CNVVF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then CNVVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
-2.05%
CNVVF - SERA
33%
Loosely correlated
N/A
UTMD - SERA
30%
Poorly correlated
+1.04%
AMIX - SERA
28%
Poorly correlated
+3.76%
HBIO - SERA
27%
Poorly correlated
+2.20%
RVTY - SERA
26%
Poorly correlated
+1.10%
More